KingMed Diagnostics as the largest independent clinical laboratory enterprise in China enjoys a market share of approximately 40%, receiving recognition from both College of American Pathologists (CAP) and ISO15189.
Dallas, TX (PRWEB) October 27, 2014
The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there was around RMB3.5 billion, up as much as 70% yr-on-yr, yet only accounting for 2%-3% of the total revenue of medical diagnosis.
There are about 110 independent clinical laboratories in today’s China, but most of them are small sized. KingMed Diagnostics, ADICON, DIAN Diagnostics and DAAN Gene as the strong performers thereof hold a combined market share of roughly 70%.
Because of a high requirement on the samples within a shorter time limit for place, the industry has a certain service radius. Therefore, a national layout is essential to business development and customer acquisition and chain-orientation the key development mode, for enterprises. KingMed Diagnostics, ADICON, DIAN Diagnostics and DAAN Gene have by far 19, 15, 14 and 8 independent medical laboratories across the country.
KingMed Diagnostics as the largest independent clinical laboratory enterprise in China enjoys a market share of approximately 40%, receiving recognition from both College of American Pathologists (CAP) and ISO15189. In the first half of 2014 it posted revenue of RMB846 million, up 37% yr-on-yr. Equipped with detection platforms for tumor diseases, genetic diseases, blood diseases, etc., KingMed Diagnostics will give top priority to tumor, reproduction and microbiological testing in the future.
Order a copy of this report @ http://www.chinamarketresearchreports.com/contacts/purchase.php?name=114945 .
ADICON is the first independent medical laboratory in domestic trans-regional chain operation, with a market share as high as 15%-18%. In recent years, many of its subsidiaries have successively won ISO15189 and CAP certificates
As an industry leader in the business model of "service + agent", DIAN Diagnostics gets involved in independent clinical laboratory, judicial expertise, diagnostic products agency and other areas. Currently, the company boasts an 18% market share in the Chinese independent clinical laboratory industry, capable of carrying out more than 1,000 medical diagnostic services.
Moreover, related enterprises abroad have also been well aware of the growth potential in China’s independent clinical laboratory industry, and set foot in the Chinese market via cooperation with local companies.
In February 2012, Quest and KingMed Diagnostics entered into a strategic alliance and established the KingMed&Quest Diagnostics Alliance Laboratory. And the Tianbo Lab jointly set up bythe South Korea-based SK Group and Xi’an Tianlong Science & Technology Co.Ltd started business in July 2014.
China Independent Clinical Laboratory Industry Report, 2014-2017 (http://www.chinamarketresearchreports.com/114945.html .) highlights the followings: Policy environment, international market, development status, competition pattern, etc. of China’s independent clinical laboratory industry;
- Upstream and downstream markets of China’s independent clinical laboratory industry and their impacts;
- Operation, independent clinical laboratory business, etc. of 13 relevant enterprises in China;
- Prospect for the development of China’s independent clinical laboratory industry in 2014-2017 and operation comparison between key players.
Major Points from Table of Contents
4. Key Players
4.3 DIAN Diagnostics
4.4 DAAN Gene
4.5 NYMPHAVN Biotechnology
4.7 Amoy Diagnostics
List of Charts
Independent Clinical Laboratory Industry Chain
Comparison of Independent Clinical Laboratory Undertakers between China and USA
Policies Concerning Independent Clinical Laboratory Industry in China, 2010-2013
U.S. Independent Clinical Laboratory Market Share by Test Item
U.S. Clinical Laboratory Market Share by Demand Side
Revenue and Net Income of Quest, 2009-2014
Gross Margin of Quest, 2009-2014
Major M&A Events of Quest Diagnostics, 2006-2014
Revenue and Operating Income of LabCorp, 2010-2013
Revenue Breakdown of LabCorp by Business, 2010-2013
Major M&A Events of LabCorp, 2007-2013
Basic Characteristics and Market Share of Major Independent Clinical Laboratory Enterprises in China, 2014
Market Size of In Vitro Diagnostic Industry in China, 2009-2013
Market Structure of In Vitro Diagnostic Industry in China, 2013
Comparison of Diagnostic Instrument Varieties between Domestic and Foreign Enterprises
Competition Pattern of Diagnostic Reagent Industry in China
IVD Revenue and Market Share of Major Diagnostic Reagent Enterprises in China, 2013
Business Revenue and Inspection Revenue of Medical Institutions in China, 2012
Medical Services of Health Agencies in China, 2012-2013
Number of Medical Institutions in China, 2012-2013
Health Expenditure and % of GDP in China, 1980-2013
Per Capita Health Expenditure and YoY Growth in China, 2006-2013E
Revenue of KingMed Diagnostics, 2012-2014
Revenue and Net Income of DIAN Diagnostics, 2009-2014
Revenue Breakdown of DIAN Diagnostics by Product, 2009-2014
Browse more reports on Life Sciences Industry @ http://www.chinamarketresearchreports.com/cat/life-sciences.html .
ChinaMarketResearchReports.com (http://www.chinamarketresearchreports.com/ .) is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.